Lantern Pharma Inc. (LTRN)
NASDAQ · Manufacturing · Pharmaceutical preparations
LTRN price, last 12 months
Key stats
- Previous close
- $0.3293
- Open
- $0.3200
- Day range
- $0.2800 – $0.3444
- 52-week range
- $0.2286 – $4.34
- Volume
- 156.9K
- Avg volume (20 days)
- 194.6K
- Market cap
- $6.5M
Performance
Technicals and fundamentals
About Lantern Pharma Inc.
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $6.5M